2015 Analysis of Clinical Chemistry and Immunodiagnostic Technologies, and Strategic Profiles of Leading Suppliers

January 2015 | 145 pages | ID: 249BD43F3E8EN
Venture Planning Group

Abstracts

This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and others.The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 145 pages

Contents

Current and Emerging Technologies

Monoclonal and Polyclonal Antibodies Immunoassays
  a. Technological Principle
  d. Chemiluminescence
  c. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    EMIT
    Electrochemical
  d. Radioimmunoassays (RIA)
  e. Immunoprecipitation
  f. Affinity Chromatography
IT and Automation
Dry Chemistry
Biosensors
Robotics
Molecular Diagnostics
  a. Detection Technologies
    1. Radioactive Methods
    2. Non- Isotopic Methods
  b. Instrumentation Reviews
    Abbott LCX
    BeckmanCoulter/Biomek FX
    Becton Dickinson
    Bio- Rad Gene Scope
    Gen- ProbeTable of Contents (Continued)
    Roche Cobas Amplicor
    Tecan LS Series
  c. Biochips Genosensor, Microarrays, Labs- on- the- Chips
Chemometrics

Competitive Profiles

Abbott Laboratories
AdnaGen
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
BioRad
Dako
DiaSorin
Eiken
Fujirebio
Instrumentation Laboratory
Kyowa Medex
Matritech
OrthoClinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE